nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromazepam—Incontinence—Furosemide—dilated cardiomyopathy	0.0569	0.0853	CcSEcCtD
Bromazepam—Ataxia—Spironolactone—dilated cardiomyopathy	0.0249	0.0374	CcSEcCtD
Bromazepam—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0204	0.0306	CcSEcCtD
Bromazepam—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.0154	0.023	CcSEcCtD
Bromazepam—Irritability—Furosemide—dilated cardiomyopathy	0.0138	0.0206	CcSEcCtD
Bromazepam—Confusional state—Spironolactone—dilated cardiomyopathy	0.0131	0.0197	CcSEcCtD
Bromazepam—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.013	0.0195	CcSEcCtD
Bromazepam—Muscular weakness—Furosemide—dilated cardiomyopathy	0.0127	0.0191	CcSEcCtD
Bromazepam—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.0125	0.0187	CcSEcCtD
Bromazepam—Somnolence—Spironolactone—dilated cardiomyopathy	0.0116	0.0174	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.0113	0.0169	CcSEcCtD
Bromazepam—Drowsiness—Furosemide—dilated cardiomyopathy	0.0111	0.0167	CcSEcCtD
Bromazepam—Diplopia—Lisinopril—dilated cardiomyopathy	0.0108	0.0162	CcSEcCtD
Bromazepam—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0107	0.0161	CcSEcCtD
Bromazepam—Irritability—Lisinopril—dilated cardiomyopathy	0.0103	0.0155	CcSEcCtD
Bromazepam—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.0103	0.0154	CcSEcCtD
Bromazepam—Ataxia—Lisinopril—dilated cardiomyopathy	0.0102	0.0153	CcSEcCtD
Bromazepam—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0096	0.0144	CcSEcCtD
Bromazepam—Eye disorder—Furosemide—dilated cardiomyopathy	0.00933	0.014	CcSEcCtD
Bromazepam—Pruritus—Spironolactone—dilated cardiomyopathy	0.00922	0.0138	CcSEcCtD
Bromazepam—Malnutrition—Furosemide—dilated cardiomyopathy	0.00869	0.013	CcSEcCtD
Bromazepam—Dizziness—Spironolactone—dilated cardiomyopathy	0.00862	0.0129	CcSEcCtD
Bromazepam—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00835	0.0125	CcSEcCtD
Bromazepam—Vomiting—Spironolactone—dilated cardiomyopathy	0.00829	0.0124	CcSEcCtD
Bromazepam—Rash—Spironolactone—dilated cardiomyopathy	0.00822	0.0123	CcSEcCtD
Bromazepam—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00821	0.0123	CcSEcCtD
Bromazepam—Vision blurred—Furosemide—dilated cardiomyopathy	0.00819	0.0123	CcSEcCtD
Bromazepam—Headache—Spironolactone—dilated cardiomyopathy	0.00816	0.0122	CcSEcCtD
Bromazepam—Agitation—Furosemide—dilated cardiomyopathy	0.00798	0.012	CcSEcCtD
Bromazepam—Nausea—Spironolactone—dilated cardiomyopathy	0.00774	0.0116	CcSEcCtD
Bromazepam—Hallucination—Lisinopril—dilated cardiomyopathy	0.00745	0.0112	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00734	0.011	CcSEcCtD
Bromazepam—Dry mouth—Furosemide—dilated cardiomyopathy	0.00723	0.0108	CcSEcCtD
Bromazepam—Confusional state—Furosemide—dilated cardiomyopathy	0.00715	0.0107	CcSEcCtD
Bromazepam—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00709	0.0106	CcSEcCtD
Bromazepam—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00695	0.0104	CcSEcCtD
Bromazepam—Skin disorder—Furosemide—dilated cardiomyopathy	0.00689	0.0103	CcSEcCtD
Bromazepam—Anorexia—Furosemide—dilated cardiomyopathy	0.00676	0.0101	CcSEcCtD
Bromazepam—Hypotension—Furosemide—dilated cardiomyopathy	0.00662	0.00993	CcSEcCtD
Bromazepam—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00656	0.00983	CcSEcCtD
Bromazepam—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00652	0.00977	CcSEcCtD
Bromazepam—Tension—Lisinopril—dilated cardiomyopathy	0.0064	0.00959	CcSEcCtD
Bromazepam—Nervousness—Lisinopril—dilated cardiomyopathy	0.00633	0.00949	CcSEcCtD
Bromazepam—Somnolence—Furosemide—dilated cardiomyopathy	0.0063	0.00945	CcSEcCtD
Bromazepam—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00627	0.00939	CcSEcCtD
Bromazepam—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00616	0.00924	CcSEcCtD
Bromazepam—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00614	0.00921	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00612	0.00918	CcSEcCtD
Bromazepam—Fatigue—Furosemide—dilated cardiomyopathy	0.00611	0.00916	CcSEcCtD
Bromazepam—Tremor—Lisinopril—dilated cardiomyopathy	0.00611	0.00915	CcSEcCtD
Bromazepam—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00584	0.00876	CcSEcCtD
Bromazepam—Palpitations—Lisinopril—dilated cardiomyopathy	0.00576	0.00864	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00551	0.00826	CcSEcCtD
Bromazepam—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00543	0.00814	CcSEcCtD
Bromazepam—Confusional state—Lisinopril—dilated cardiomyopathy	0.00536	0.00804	CcSEcCtD
Bromazepam—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00532	0.00797	CcSEcCtD
Bromazepam—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00522	0.00783	CcSEcCtD
Bromazepam—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00519	0.00778	CcSEcCtD
Bromazepam—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00517	0.00775	CcSEcCtD
Bromazepam—Asthenia—Furosemide—dilated cardiomyopathy	0.00509	0.00763	CcSEcCtD
Bromazepam—Anorexia—Lisinopril—dilated cardiomyopathy	0.00507	0.0076	CcSEcCtD
Bromazepam—Pruritus—Furosemide—dilated cardiomyopathy	0.00502	0.00752	CcSEcCtD
Bromazepam—Hypotension—Lisinopril—dilated cardiomyopathy	0.00497	0.00745	CcSEcCtD
Bromazepam—Somnolence—Lisinopril—dilated cardiomyopathy	0.00473	0.00709	CcSEcCtD
Bromazepam—Dizziness—Furosemide—dilated cardiomyopathy	0.00469	0.00703	CcSEcCtD
Bromazepam—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00468	0.00702	CcSEcCtD
Bromazepam—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00462	0.00693	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00459	0.00688	CcSEcCtD
Bromazepam—Fatigue—Lisinopril—dilated cardiomyopathy	0.00459	0.00688	CcSEcCtD
Bromazepam—Vomiting—Furosemide—dilated cardiomyopathy	0.00451	0.00676	CcSEcCtD
Bromazepam—Rash—Furosemide—dilated cardiomyopathy	0.00447	0.0067	CcSEcCtD
Bromazepam—Dermatitis—Furosemide—dilated cardiomyopathy	0.00447	0.0067	CcSEcCtD
Bromazepam—Headache—Furosemide—dilated cardiomyopathy	0.00444	0.00666	CcSEcCtD
Bromazepam—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00438	0.00657	CcSEcCtD
Bromazepam—Nausea—Furosemide—dilated cardiomyopathy	0.00421	0.00631	CcSEcCtD
Bromazepam—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00392	0.00588	CcSEcCtD
Bromazepam—Asthenia—Lisinopril—dilated cardiomyopathy	0.00382	0.00572	CcSEcCtD
Bromazepam—Pruritus—Lisinopril—dilated cardiomyopathy	0.00376	0.00564	CcSEcCtD
Bromazepam—Dizziness—Lisinopril—dilated cardiomyopathy	0.00352	0.00527	CcSEcCtD
Bromazepam—Vomiting—Lisinopril—dilated cardiomyopathy	0.00338	0.00507	CcSEcCtD
Bromazepam—Rash—Lisinopril—dilated cardiomyopathy	0.00335	0.00503	CcSEcCtD
Bromazepam—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00335	0.00502	CcSEcCtD
Bromazepam—Headache—Lisinopril—dilated cardiomyopathy	0.00333	0.005	CcSEcCtD
Bromazepam—GABRG3—Ion channel transport—PLN—dilated cardiomyopathy	0.0033	0.00992	CbGpPWpGaD
Bromazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00326	0.00979	CbGpPWpGaD
Bromazepam—GABRB1—Ion channel transport—PLN—dilated cardiomyopathy	0.00325	0.00977	CbGpPWpGaD
Bromazepam—GABRR1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00317	0.00951	CbGpPWpGaD
Bromazepam—GABRA6—Ion channel transport—RYR2—dilated cardiomyopathy	0.00316	0.0095	CbGpPWpGaD
Bromazepam—Nausea—Lisinopril—dilated cardiomyopathy	0.00316	0.00474	CcSEcCtD
Bromazepam—GABRA4—Ion channel transport—RYR2—dilated cardiomyopathy	0.00312	0.00938	CbGpPWpGaD
Bromazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00308	0.00926	CbGpPWpGaD
Bromazepam—GABRA6—Ion channel transport—PLN—dilated cardiomyopathy	0.00308	0.00924	CbGpPWpGaD
Bromazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00304	0.00914	CbGpPWpGaD
Bromazepam—GABRA4—Ion channel transport—PLN—dilated cardiomyopathy	0.00304	0.00913	CbGpPWpGaD
Bromazepam—GABRR2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00302	0.00907	CbGpPWpGaD
Bromazepam—GABRQ—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00302	0.00907	CbGpPWpGaD
Bromazepam—GABRB2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00286	0.00858	CbGpPWpGaD
Bromazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00278	0.00836	CbGpPWpGaD
Bromazepam—GABRB2—Ion channel transport—PLN—dilated cardiomyopathy	0.00278	0.00835	CbGpPWpGaD
Bromazepam—GABRA5—Ion channel transport—RYR2—dilated cardiomyopathy	0.00278	0.00834	CbGpPWpGaD
Bromazepam—GABRA3—Ion channel transport—RYR2—dilated cardiomyopathy	0.00273	0.00819	CbGpPWpGaD
Bromazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0027	0.00812	CbGpPWpGaD
Bromazepam—GABRA5—Ion channel transport—PLN—dilated cardiomyopathy	0.0027	0.00811	CbGpPWpGaD
Bromazepam—GABRA2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00268	0.00805	CbGpPWpGaD
Bromazepam—GABRB3—Ion channel transport—RYR2—dilated cardiomyopathy	0.00266	0.00799	CbGpPWpGaD
Bromazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00266	0.00798	CbGpPWpGaD
Bromazepam—GABRA3—Ion channel transport—PLN—dilated cardiomyopathy	0.00265	0.00796	CbGpPWpGaD
Bromazepam—GABRG2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00261	0.00785	CbGpPWpGaD
Bromazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00261	0.00784	CbGpPWpGaD
Bromazepam—GABRA2—Ion channel transport—PLN—dilated cardiomyopathy	0.00261	0.00783	CbGpPWpGaD
Bromazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00259	0.00779	CbGpPWpGaD
Bromazepam—GABRB3—Ion channel transport—PLN—dilated cardiomyopathy	0.00259	0.00778	CbGpPWpGaD
Bromazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00255	0.00765	CbGpPWpGaD
Bromazepam—GABRG2—Ion channel transport—PLN—dilated cardiomyopathy	0.00254	0.00764	CbGpPWpGaD
Bromazepam—GABRR1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00253	0.0076	CbGpPWpGaD
Bromazepam—GABRG3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00249	0.00747	CbGpPWpGaD
Bromazepam—GABRB1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00245	0.00736	CbGpPWpGaD
Bromazepam—GABRR1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00243	0.00728	CbGpPWpGaD
Bromazepam—GABRR2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00241	0.00725	CbGpPWpGaD
Bromazepam—GABRQ—Neuronal System—ABCC9—dilated cardiomyopathy	0.00241	0.00725	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00235	0.00707	CbGpPWpGaD
Bromazepam—GABRA6—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00232	0.00696	CbGpPWpGaD
Bromazepam—GABRR2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00231	0.00695	CbGpPWpGaD
Bromazepam—GABRQ—Neuronal System—ACTN2—dilated cardiomyopathy	0.00231	0.00695	CbGpPWpGaD
Bromazepam—GABRA4—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00229	0.00687	CbGpPWpGaD
Bromazepam—GABRA1—Ion channel transport—RYR2—dilated cardiomyopathy	0.00228	0.00686	CbGpPWpGaD
Bromazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00223	0.00669	CbGpPWpGaD
Bromazepam—GABRA1—Ion channel transport—PLN—dilated cardiomyopathy	0.00222	0.00667	CbGpPWpGaD
Bromazepam—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.0022	0.0066	CbGpPWpGaD
Bromazepam—GABRB2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00209	0.00629	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00203	0.00611	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.002	0.006	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00199	0.00597	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00196	0.00589	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00196	0.00588	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00195	0.00586	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00191	0.00575	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00191	0.00572	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00188	0.00564	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—ABCC9—dilated cardiomyopathy	0.00185	0.00556	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—ABCC9—dilated cardiomyopathy	0.00183	0.00549	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—ACTN2—dilated cardiomyopathy	0.00178	0.00533	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—ACTN2—dilated cardiomyopathy	0.00175	0.00527	CbGpPWpGaD
Bromazepam—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00171	0.00515	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00167	0.00503	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00167	0.00502	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—ABCC9—dilated cardiomyopathy	0.00163	0.00488	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—ACTN2—dilated cardiomyopathy	0.0016	0.00482	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—ABCC9—dilated cardiomyopathy	0.0016	0.00479	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00157	0.00471	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—ACTN2—dilated cardiomyopathy	0.00156	0.00468	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00156	0.00468	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00153	0.0046	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00153	0.0046	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.0015	0.00452	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.0015	0.00452	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00149	0.00449	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00147	0.00441	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00146	0.00439	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00146	0.00439	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00143	0.00431	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00143	0.00431	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.0014	0.00419	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.0014	0.00419	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.0014	0.00419	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.0014	0.00419	CbGpPWpGaD
Bromazepam—CYP2E1—Vitamin A and Carotenoid Metabolism—CD36—dilated cardiomyopathy	0.00139	0.00417	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00136	0.00409	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00134	0.00402	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.0013	0.0039	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.0013	0.0039	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00128	0.00385	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00118	0.00355	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00116	0.0035	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00115	0.00345	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00115	0.00345	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00113	0.0034	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00113	0.0034	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.0011	0.00331	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00109	0.00327	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00107	0.00322	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00107	0.00322	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00107	0.00321	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00106	0.00318	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00106	0.00318	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00105	0.00316	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000996	0.00299	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000995	0.00299	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000983	0.00295	CbGpPWpGaD
Bromazepam—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000975	0.00293	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000967	0.00291	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000967	0.00291	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000966	0.0029	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.000963	0.00289	CbGpPWpGaD
Bromazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000958	0.00288	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000949	0.00285	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00094	0.00282	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00094	0.00282	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000932	0.0028	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000926	0.00278	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000923	0.00277	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000923	0.00277	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000919	0.00276	CbGpPWpGaD
Bromazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000914	0.00274	CbGpPWpGaD
Bromazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000914	0.00274	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00091	0.00273	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000907	0.00272	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000907	0.00272	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000901	0.00271	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000901	0.00271	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000899	0.0027	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000885	0.00266	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000885	0.00266	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000874	0.00262	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.00087	0.00261	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000858	0.00258	CbGpPWpGaD
Bromazepam—GABRR1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000852	0.00256	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000843	0.00253	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000838	0.00252	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000823	0.00247	CbGpPWpGaD
Bromazepam—GABRR2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000813	0.00244	CbGpPWpGaD
Bromazepam—GABRQ—Ion channel transport—RAF1—dilated cardiomyopathy	0.000813	0.00244	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000797	0.00239	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000795	0.00239	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000791	0.00237	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000773	0.00232	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000773	0.00232	CbGpPWpGaD
Bromazepam—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000759	0.00228	CbGpPWpGaD
Bromazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000753	0.00226	CbGpPWpGaD
Bromazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000741	0.00223	CbGpPWpGaD
Bromazepam—GABRR1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00072	0.00216	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000719	0.00216	CbGpPWpGaD
Bromazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000701	0.00211	CbGpPWpGaD
Bromazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000693	0.00208	CbGpPWpGaD
Bromazepam—GABRQ—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000687	0.00206	CbGpPWpGaD
Bromazepam—GABRR2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000687	0.00206	CbGpPWpGaD
Bromazepam—GABRG3—Ion channel transport—RAF1—dilated cardiomyopathy	0.00067	0.00201	CbGpPWpGaD
Bromazepam—GABRB1—Ion channel transport—RAF1—dilated cardiomyopathy	0.00066	0.00198	CbGpPWpGaD
Bromazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000633	0.0019	CbGpPWpGaD
Bromazepam—GABRA6—Ion channel transport—RAF1—dilated cardiomyopathy	0.000624	0.00187	CbGpPWpGaD
Bromazepam—GABRA4—Ion channel transport—RAF1—dilated cardiomyopathy	0.000616	0.00185	CbGpPWpGaD
Bromazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000615	0.00185	CbGpPWpGaD
Bromazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000604	0.00182	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000603	0.00181	CbGpPWpGaD
Bromazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000594	0.00178	CbGpPWpGaD
Bromazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00059	0.00177	CbGpPWpGaD
Bromazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000579	0.00174	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.000577	0.00173	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000567	0.0017	CbGpPWpGaD
Bromazepam—GABRG3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000566	0.0017	CbGpPWpGaD
Bromazepam—GABRB2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000564	0.00169	CbGpPWpGaD
Bromazepam—GABRB1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000557	0.00167	CbGpPWpGaD
Bromazepam—GABRR1—Neuronal System—RAF1—dilated cardiomyopathy	0.000552	0.00166	CbGpPWpGaD
Bromazepam—GABRA5—Ion channel transport—RAF1—dilated cardiomyopathy	0.000548	0.00164	CbGpPWpGaD
Bromazepam—GABRA3—Ion channel transport—RAF1—dilated cardiomyopathy	0.000538	0.00162	CbGpPWpGaD
Bromazepam—GABRA2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000528	0.00159	CbGpPWpGaD
Bromazepam—GABRA6—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000527	0.00158	CbGpPWpGaD
Bromazepam—GABRR2—Neuronal System—RAF1—dilated cardiomyopathy	0.000526	0.00158	CbGpPWpGaD
Bromazepam—GABRQ—Neuronal System—RAF1—dilated cardiomyopathy	0.000526	0.00158	CbGpPWpGaD
Bromazepam—GABRB3—Ion channel transport—RAF1—dilated cardiomyopathy	0.000525	0.00158	CbGpPWpGaD
Bromazepam—GABRA4—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000521	0.00156	CbGpPWpGaD
Bromazepam—GABRG2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000516	0.00155	CbGpPWpGaD
Bromazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000506	0.00152	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000494	0.00148	CbGpPWpGaD
Bromazepam—GABRB2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000476	0.00143	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00047	0.00141	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000463	0.00139	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000454	0.00136	CbGpPWpGaD
Bromazepam—GABRA1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000451	0.00135	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000446	0.00134	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000444	0.00133	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000442	0.00133	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000436	0.00131	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—RAF1—dilated cardiomyopathy	0.000434	0.0013	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—RAF1—dilated cardiomyopathy	0.000427	0.00128	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—RAF1—dilated cardiomyopathy	0.000404	0.00121	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—RAF1—dilated cardiomyopathy	0.000399	0.0012	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000381	0.00114	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—RAF1—dilated cardiomyopathy	0.000365	0.0011	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—RAF1—dilated cardiomyopathy	0.000354	0.00106	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—RAF1—dilated cardiomyopathy	0.000348	0.00105	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000348	0.00105	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—RAF1—dilated cardiomyopathy	0.000342	0.00103	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—RAF1—dilated cardiomyopathy	0.00034	0.00102	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000339	0.00102	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000339	0.00102	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—RAF1—dilated cardiomyopathy	0.000334	0.001	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	0.000327	0.000983	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000323	0.000969	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000323	0.000969	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000303	0.000911	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000297	0.000891	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	0.000296	0.000889	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—RAF1—dilated cardiomyopathy	0.000292	0.000876	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000283	0.00085	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000283	0.00085	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	0.000269	0.000807	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	0.000252	0.000758	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000233	0.0007	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.00023	0.00069	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	0.000228	0.000686	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000217	0.000652	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000215	0.000644	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000209	0.000628	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	0.000197	0.000591	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000196	0.000589	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000191	0.000572	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000187	0.000562	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000184	0.000552	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000183	0.000549	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000179	0.000539	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	0.000178	0.000534	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000161	0.000485	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000157	0.000471	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000152	0.000456	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000139	0.000418	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.000137	0.000412	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000136	0.000407	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000122	0.000367	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000109	0.000326	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000106	0.000317	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	9.52e-05	0.000286	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	8.04e-05	0.000241	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	7.83e-05	0.000235	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	7.05e-05	0.000212	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	6.2e-05	0.000186	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	6.04e-05	0.000181	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	5.44e-05	0.000163	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	4.83e-05	0.000145	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	4.71e-05	0.000141	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	4.24e-05	0.000127	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	3.73e-05	0.000112	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	3.63e-05	0.000109	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	3.27e-05	9.82e-05	CbGpPWpGaD
